| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2295062A1 Hydrazine derivatives |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2291758A1 2-substituted 4,5-diaryl imidazoles |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889884A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | EP0804202A4 Estrogens and parathyroid hormone for treating osteoporosis |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use |
| 01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888323A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | EP0888292A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY $g(a)v$g(b)3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | DE19829229A1 Hydrazinderivate Hydrazine |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1204245A Bone grafting matrix |
| 01/05/1999 | US5856446 Method of treating rheumatoid arthritis with low dose type II collagen |
| 01/05/1999 | US5856358 Prevent bone erosion |
| 01/05/1999 | US5856356 Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis |
| 01/05/1999 | US5856341 Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/1999 | US5856314 Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 01/05/1999 | US5856138 Human parathyroid hormone muteins and production thereof |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236452A1 Gida1 |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/30/1998 | WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 12/30/1998 | WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 12/30/1998 | WO1998058913A1 Chalcones having antiproliferative activity |
| 12/30/1998 | WO1998058911A2 Prostaglandin agonists |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058641A1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
| 12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 12/30/1998 | CN1203100A Medicinal liquor for curing rheumatism |
| 12/30/1998 | CN1203098A Chinese medicine for curing aseptic necrosis of head of femur |
| 12/30/1998 | CN1203088A Medicinal liquor for treating suppurative bone infection |
| 12/30/1998 | CA2294601A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 12/30/1998 | CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/29/1998 | US5854207 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 12/29/1998 | US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same |
| 12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
| 12/24/1998 | CA2234418A1 Human afc1 |
| 12/24/1998 | CA2234402A1 Human rce1 |
| 12/23/1998 | WO1998057972A1 Quaternary ammonium compounds as tachykinin antagonists |
| 12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 12/23/1998 | WO1998057939A1 Crystalline roxifiban |
| 12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 12/23/1998 | WO1998057919A1 Selective thyroid hormone analogs |
| 12/23/1998 | WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 12/23/1998 | WO1998057656A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
| 12/23/1998 | EP0885299A1 Wsx receptor and ligands |
| 12/23/1998 | EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 12/23/1998 | CN1202907A Cyclopeptide derivatives |
| 12/23/1998 | CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists |
| 12/23/1998 | CN1202818A Solubilisation method |
| 12/23/1998 | CA2698626A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 12/23/1998 | CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 12/23/1998 | CA2294047A1 Crystalline roxifiban |
| 12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |